Institutional members access full text with Ovid®

Share this article on:

Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience

Woods, Gary M. MD*; Stanek, Joseph MS; Harrison, Sheilah BSc; Texter, Karen MD§; Kerlin, Bryce A. MD; Dunn, Amy L. MD; Kumar, Riten MD, MSc

Journal of Pediatric Hematology/Oncology: October 2017 - Volume 39 - Issue 7 - p 576–577
doi: 10.1097/MPH.0000000000000966
Letters to the Editor

*Department of Pediatrics, Eastern Virginia Medical School, Division of Hematology/Oncology, Children’s Hospital of the King’s Daughters, Norfolk, VA

Department of Pediatrics, Division of Hematology/Oncology

§Department of Pediatrics, Division of Cardiology, The Ohio State University

Quality Improvement Services, Nationwide Children’s Hospital, Columbus, OH

The authors declare no conflict of interest.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.